Cite

HARVARD Citation

    Young, L. et al. (n.d.). 644 Ocular adverse events associated with programmed death-1 and programmed death ligand-1 immunotherapy. Journal for immunotherapy of cancer. pp. A386-A387. [Online]. 
  
Back to record